Literature DB >> 31782834

Prognostic value of the preoperative neutrophil-lymphocyte ratio in patients undergoing the bidirectional Glenn procedure.

Valdano Manuel1,2, Leonardo A Miana1, Gustavo P Guerreiro1, Davi F Tenório1, Aida Turquetto1, Juliano G Penha1, Maria R Massoti1, Carla Tanamati1, António P F Junior2, Luiz F Caneo1, Fábio B Jatene1, Marcelo B Jatene1.   

Abstract

INTRODUCTION: The neutrophil-lymphocyte ratio (NLR) has been associated with worse outcomes in patients undergoing coronary artery bypass graft surgery. Little is known about this association in the pediatric population who require surgery for congenital heart defects, especially in patients with a single ventricle (SV).
OBJECTIVE: To analyze the association of the preoperative NLR with outcomes in patients undergoing the bidirectional Glenn procedure.
METHODS: This study involved a retrospective cohort analysis of 141 consecutive patients with SV undergoing the bidirectional Glenn procedure between January 2011 and December 2017 in two centers. The preoperative NLR was included in the last hemogram test before surgery. According to the NLR level, the patients were divided into group I (NLR < 1), group II (NLR between 1 and 2), and group III (NLR > 2). The primary endpoint was total hospital length of stay (LOS), and secondary endpoints were mechanical ventilation (MV) time, intensive care unit (ICU) LOS, ventricular dysfunction, complications, and middle-term mortality.
RESULTS: The average follow-up duration was 48 months. There were 61, 47, and 33 patients in groups I, II, and III, respectively. Patients in group III exhibited an increased risk of prolonged total hospital LOS (P = .00). An increase in MV time (P = .03) and ICU LOS (P = .02) was also observed in this group, and these patients experienced greater mortality in 24 months following the surgery (P = .03). There was no association between the NLR and ventricular dysfunction (P = .26) and complications (P = .46).
CONCLUSION: A high preoperative NLR was associated with worse outcomes in patients with SV physiology undergoing the bidirectional Glenn procedure.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  bidirectional Glenn procedure; congenital heart disease; neutrophil-lymphocyte ratio; single-ventricle physiology

Mesh:

Year:  2019        PMID: 31782834     DOI: 10.1111/jocs.14381

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  5 in total

1.  Risk factors and outcomes associated with acute kidney injury following extracardiac total cavopulmonary connection: a retrospective observational study.

Authors:  Liting Bai; Yu Jin; Peiyao Zhang; Yixuan Li; Peng Gao; Wenting Wang; Xu Wang; Zhengyi Feng; Ju Zhao; Jinping Liu
Journal:  Transl Pediatr       Date:  2022-06

2.  The association between neutrophil-lymphocyte ratio and poor outcomes following infant cardiac surgery.

Authors:  Peng Gao; Jinping Liu; Xu Wang; Peiyao Zhang; Yu Jin; Liting Bai; Yixuan Li
Journal:  BMC Cardiovasc Disord       Date:  2021-11-08       Impact factor: 2.298

3.  Preoperative lymphocyte percentage and neutrophil-lymphocyte ratio are useful predictors of 30-day postoperative complications after lumbar fusion.

Authors:  Temidayo Osunronbi; Balint Borbas; Hiba Lusta; Agbolahan Sofela; Himanshu Sharma
Journal:  Surg Neurol Int       Date:  2022-04-15

4.  Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio in Univentricular Patients From Birth to Follow-Up After Fontan-Predicting Lymphatic Abnormalities.

Authors:  Julia Moosmann; Christian Schroeder; Robert Cesnjevar; Kathrin Rottermann; Annika Weigelt; Sven Dittrich
Journal:  Front Pediatr       Date:  2021-12-08       Impact factor: 3.418

5.  Preoperative Neutrophil-Lymphocyte Ratio Can Predict Outcomes for Patients Undergoing Tetralogy of Fallot Repair.

Authors:  Valdano Manuel; Leonardo A Miana; Gustavo Pampolha Guerreiro; Aida Turquetto; Rômullo Medeiros Santos; Natália Fernandes; Davi Freitas Tenório; Luiz Fernando Caneo; Fabio B Jatene; Marcelo Biscegli Jatene
Journal:  Braz J Cardiovasc Surg       Date:  2021-10-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.